Publications by authors named "John D Clemens"

Background: Patients with cholera have been shown to be protected against subsequent cholera for 3 years after their initial episode. We aimed to assess protection at 10 years of follow-up.

Methods: In this retrospective cohort study, cohorts of patients treated for cholera (index patients) and contemporaneously selected age-matched individuals without cholera (controls), randomly selected from the population of Matlab, Bangladesh, were assembled between 1990 and 2009 and followed for up to 10 years.

View Article and Find Full Text PDF

Objective: In COVID-19, cytokine storms (CS) result in higher mortality and morbidity. Our study evaluated the rate of cytokine storms among COVID-positive Bangladeshi adults.

Methods: From October 2020 to March 2022, this cohort study enrolled both COVID-positive and COVID-negative healthy adults.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to understand how long the protection from the typhoid conjugate vaccine (TCV) lasts by extending research from the TyVAC trial in Bangladesh to 5 years post-vaccination.
  • - It found that children who received the TCV between 2018-2019 had a significantly higher risk of contracting typhoid compared to those vaccinated more recently, indicating that vaccine effectiveness declines over time.
  • - The research showed an estimated vaccine effectiveness of only 50% in the 3-5 year period after vaccination, highlighting the need for further studies on booster doses to maintain immunity.
View Article and Find Full Text PDF

Background: Vaccination constitutes an attractive control measure for hepatitis E virus (HEV), a major cause of maternal and perinatal mortality globally. Analysis of pregnant participants in an effectiveness trial of the HEV vaccine HEV239 showed possible HEV239-associated fetal losses. We aimed to conduct a detailed analysis of this safety signal.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted in Bangladesh to evaluate the safety and effectiveness of a recombinant hepatitis E vaccine (HEV239) in preventing hepatitis E during pregnancy, focusing on pregnant and non-pregnant women aged 16-39.
  • The trial involved 67 villages and included over 19,000 participants who received either HEV239 or a control hepatitis B vaccine (Hepa-B), with follow-up for two years post-vaccination.
  • Results showed no cases of hepatitis E among pregnant participants in either group, indicating HEV239's mild safety profile was comparable to Hepa-B, with no significant adverse events reported.
View Article and Find Full Text PDF
Article Synopsis
  • Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi A, poses a significant public health issue due to rising antimicrobial resistance, complicating treatment options and worsening health outcomes.
  • *The study sequenced bacteria samples from blood cultures of febrile patients in urban sites of Dhaka (Bangladesh), Kathmandu (Nepal), and Blantyre (Malawi) to analyze their genetic characteristics and resistance mechanisms.
  • *Findings revealed that different genotypes of S. Typhi were present across the sites, with high rates of multidrug resistance in Blantyre and Dhaka but not in Kathmandu, highlighting diverse transmission dynamics and resistance patterns.
View Article and Find Full Text PDF

Background: Salmonella enterica serotype Typhi (Salmonella Typhi) causes severe and occasionally life-threatening disease, transmitted through contaminated food and water. Humans are the only reservoir, inadequate water, sanitation, and hygiene infrastructure increases risk of typhoid. High-quality data to assess spatial and temporal relationships in disease dynamics are scarce.

View Article and Find Full Text PDF

Background: Given the waning of vaccine effectiveness and the shifting of the most dominant strains in the U.S., it is imperative to understand the association between vaccination coverage and Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) disease and mortality at the community levels and whether that association might vary according to the dominant SARS-CoV-2 strains in the U.

View Article and Find Full Text PDF

Background: is an important cause of diarrhea in Bangladeshi children <5 years of age, with an incidence rate of 4.6 per 100 person-years. However, the report was more than a decade old, and data on consequences are similarly outdated and heterogeneously collected.

View Article and Find Full Text PDF

Background: The safety and efficacy of bubble continuous positive airway pressure (bCPAP) for treatment of childhood severe pneumonia outside tertiary care hospitals is uncertain. We did a cluster-randomised effectiveness trial of locally made bCPAP compared with WHO-recommended low-flow oxygen therapy in children with severe pneumonia and hypoxaemia in general hospitals in Ethiopia.

Methods: This open, cluster-randomised trial was done in 12 general (secondary) hospitals in Ethiopia.

View Article and Find Full Text PDF

Background: Typhoid Fever remains a major cause of morbidity and mortality in low-income settings. The Severe Typhoid in Africa programme was designed to address regional gaps in typhoid burden data and identify populations eligible for interventions using novel typhoid conjugate vaccines.

Methods: A hybrid design, hospital-based prospective surveillance with population-based health-care utilisation surveys, was implemented in six countries in sub-Saharan Africa.

View Article and Find Full Text PDF

Background: Oral cholera vaccine (OCV) and incremental improvements in household water, sanitation, and hygiene (WASH) within cholera-endemic areas can reduce cholera risk. However, we lack empiric evaluation of their combined impact.

Methods: We evaluated a cluster-randomized, placebo-controlled trial of OCV (Shanchol) in Kolkata, India.

View Article and Find Full Text PDF

Background: After the completion of a randomized trial at Dhaka Hospital in 2013, bubble continuous positive airway pressure (BCPAP) oxygen therapy was incorporated as the part of the standard treatment for children with severe pneumonia with hypoxemia in an intensive care unit at Dhaka Hospital in August 2013 instead of World Health Organization (WHO) standard low flow oxygen therapy.

Objective: To understand the long-term effectiveness of the introduction of bCPAP oxygen therapy by comparing pneumonia mortality in the post-trial period (August 2013 to December 2017) with the pre-trial (February 2009 to July 2011) and trial periods (August 2011 to July 2013).

Methods: It was a retrospective analysis of prospectively collected hospital data of all admissions.

View Article and Find Full Text PDF

Background: Global cholera control efforts rely heavily on effective water, sanitation, and hygiene (WASH) interventions in cholera-endemic settings.

Methods: Using data from a large, randomized controlled trial of oral cholera vaccine conducted in Kolkata, India, we evaluated whether natural variations in WASH in an urban slum setting were predictive of cholera risk. From the control population (n = 55 086), baseline WASH data from a randomly selected "training subpopulation" (n = 27 634) were analyzed with recursive partitioning to develop a dichotomous ("better" vs "not better") composite household WASH variable from several WASH features collected at baseline, and this composite variable was then evaluated in a mutually exclusive "validation population" (n = 27 452).

View Article and Find Full Text PDF

Background: Bubble continuous positive airway pressure (bCPAP) oxygen therapy has been shown to be safe and effective in treating children with severe pneumonia and hypoxaemia in Bangladesh. Due to lack of adequate non-invasive ventilatory support during coronavirus disease 2019 (COVID-19) crisis, we aimed to evaluate whether bCPAP was safe and feasible when adapted for use in adults with similar indications.

Methods: Adults (18-64 years) with severe pneumonia and moderate hypoxaemia (80 to <90% oxygen saturation (SpO) in room air) were provided bCPAP via nasal cannula at a flow rate of 10 litres per minute (l/min) oxygen at 10 centimetres (cm) HO pressure, in two tertiary hospitals in Dhaka, Bangladesh.

View Article and Find Full Text PDF

Background: Typhoid fever, or enteric fever, is a highly fatal infectious disease that affects over 9 million people worldwide each year, resulting in more than 110,000 deaths. Reduction in the burden of typhoid in low-income countries is crucial for public health and requires the implementation of feasible water, sanitation, and hygiene (WASH) interventions, especially in densely populated urban slums.

Objective: In this study, conducted in Mirpur, Bangladesh, we aimed to assess the association between household WASH status and typhoid risk in a training subpopulation of a large prospective cohort (n=98,087), and to evaluate the performance of a machine learning algorithm in creating a composite WASH variable.

View Article and Find Full Text PDF

Background: The Global Typhoid Genomics Consortium was established to bring together the typhoid research community to aggregate and analyse serovar Typhi (Typhi) genomic data to inform public health action. This analysis, which marks 22 years since the publication of the first Typhi genome, represents the largest Typhi genome sequence collection to date (n=13,000).

Methods: This is a meta-analysis of global genotype and antimicrobial resistance (AMR) determinants extracted from previously sequenced genome data and analysed using consistent methods implemented in open analysis platforms GenoTyphi and Pathogenwatch.

View Article and Find Full Text PDF
Article Synopsis
  • Effective management of hypoxaemia is crucial for reducing pneumonia deaths in children, and the use of bubble continuous positive airway pressure (bCPAP) therapy has shown promise in intensive care settings in Bangladesh.
  • A qualitative assessment was conducted to evaluate the structural and functional capacity of district hospitals for implementing bCPAP, involving interviews with healthcare staff and parents, as well as an analysis of pneumonia cases over 12 months.
  • Challenges for implementation included a shortage of essential medical equipment, insufficient staffing, high patient loads, and the need for improved routine care, leading to recommendations for more regular clinical reviews.
View Article and Find Full Text PDF

Background: A cluster-randomised trial of Vi-tetanus toxoid (Vi-TT) conjugate vaccine conducted in urban Bangladeshi children found a high level of direct protection by Vi-TT but no significant vaccine herd protection. We reassessed the trial using a "fried egg" analysis to evaluate whether herd protection might have been obscured by transmission of typhoid into the clusters from the outside.

Methods: A participant- and observer-blind, cluster-randomised trial was conducted between February 14, 2018 and August 12, 2019 in three wards of Mirpur, a densely populated urban area of Dhaka, Bangladesh.

View Article and Find Full Text PDF
Article Synopsis
  • - A cluster-randomized trial in Dhaka, Bangladesh, compared the Vi-TT vaccine with the JE vaccine as a control to evaluate immune responses in children.
  • - A total of 1,500 children were selected in a 2:1 ratio (Vi-TT to JE) and blood samples were taken before vaccination and several times after, measuring anti-Vi-IgG response.
  • - The results showed that a single dose of Vi-TT produced a strong and lasting antibody response for at least two years, which could help in understanding population protection against the disease in the future.
View Article and Find Full Text PDF

Background: Despite the advancement in our understanding of cholera and its etiological agent, Vibrio cholerae, the prevention and treatment of the disease are often hindered due to rapid changes in drug response pattern, serotype, and the major genomic islands namely, the CTX-prophage, and related genetic characteristics. In the present study, V. cholerae (n = 172) associated with endemic cholera in Dhaka during the years 2015-2021 were analyzed for major phenotypic and genetic characteristics, including drug resistance patterns.

View Article and Find Full Text PDF

The current global initiative to end Cholera by 2030 emphasizes the use of oral cholera vaccine (OCV) combined with feasible household Water-Sanitation-Hygiene (WASH) interventions. However, little is known about how improved WASH practices and behaviors and OCV interact to reduce the risk of cholera. We reanalyzed two arms of a cluster-randomized trial in urban Bangladesh, to evaluate the effectiveness of OCV given as a 2-dose regimen.

View Article and Find Full Text PDF

Background: From May to December 2021, Bangladesh experienced a major surge in the Delta variant of SARS-CoV-2. The earlier rollout of several vaccines offered the opportunity to evaluate vaccine effectiveness against this variant.

Methods: A prospective, test-negative case-control study was conducted in five large hospitals in Dhaka between September and December 2021.

View Article and Find Full Text PDF
Article Synopsis
  • * The study focused on the cost-effectiveness of vaccinating children aged 1 to 14 with the OCV Shanchol, estimating the total societal cost of full vaccination at US$ 6.11 per individual, factoring in both delivery and administration costs.
  • * Findings revealed that the costs for delivering OCV to children were higher than those in campaigns targeting all age groups, suggesting that tailored vaccination strategies may come with extra financial challenges, highlighting the need to address these costs for efficient implementation of vaccination programs in resource-limited
View Article and Find Full Text PDF